2021 annual financial data
China SXT Pharmaceuticals 2021 Operating cash flow margin
China SXT Pharmaceuticals 2021 operating cash flow margin with verified reporte…
Direct answer
Operating cash flow margin was -27.56%.
Operating income was -2,197,076 USD and net income was -2,748,183 USD.
Operating cash flow was -1,316,561 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,777,573 USD
- Operating income
- -2,197,076 USD
- Net income
- -2,748,183 USD
- Operating cash flow
- -1,316,561 USD